Cardiovascular Disease
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
41 companies ranked by most advanced pipeline stage
+11 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 167,559 patients across 50 trials
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects
Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
COcoa Supplement and Multivitamin Outcomes Study
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
Ticagrelor vs. Prasugrel Effects on Infarct Size
Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
Effect of Pulse Fractions on Indices on Cardiovascular Disease and Diabetes Risk Factors
Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women
Safety and Feasibility of the Injectable BL-1040 Implant
A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831
Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers
Effect of BIA 5 1058 on Cardiac Repolarization
A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects
FEIBA and Use of Blood Products in Cardiac Surgery
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants
PK Study of IV Formulation of GW856553
An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)
Technology-enabled Cardiac Rehabilitation Through PATHway. Feasibility, Clinical Effectiveness and Cost-effectiveness
Bridging Income Generation With Group Integrated Care
Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI
A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
The Northwest Coalition for Primary Care Practice Support
The Miami Heart Study at Baptist Health South Florida
The Use of Texting Messaging to Improve the Hospital-to-community Transition Period in Cardiovascular Disease Patients
Soybean Oil Trial of cArdiovascular Risk
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Related Jobs
Associate Director, Clinical Trial Lead (Princeton, NJ/ South San Francisco)
Director, Facilities
Medical Advisor Cardiology
Medical Advisor Cardiology
Director, Clinical Quality Lead
Executive Director, Head of Global Site Management
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.